Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | CXCR3 | P49682 | 16/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nopol SCHEMBL5309650 | 1.00 | TSHR (0.55) | TSHRKDM4EHTTTDP1KCNH2 | |
| Nopol SCHEMBL9723502 | 1.00 | TSHR (0.55) | TSHRKDM4EHTTTDP1KCNH2 | |
| Nopol SCHEMBL17187721 | 1.00 | TSHR (0.55) | TSHRKDM4EHTTTDP1KCNH2 | |
| Nopol SCHEMBL10687292 | 1.00 | TSHR (0.55) | TSHRKDM4EHTTTDP1KCNH2 | |
| Nopol SCHEMBL8610441 | 1.00 | TSHR (0.55) | TSHRKDM4EHTTTDP1KCNH2 | |
| Nopol SCHEMBL114153 | 1.00 | TSHR (0.55) | TSHRKDM4EHTTTDP1KCNH2 | |
| Nopol SCHEMBL2302936 | 0.97 | KCNH2 (0.55) | TSHRKDM4EHTTTDP1KCNH2 | |
| Nopol SCHEMBL7925157 | 0.95 | KCNH2 (0.53) | TSHRKDM4EHTTTDP1KCNH2 | |
| SCHEMBL31033376 | 0.90 | TSHR (0.52) | TSHRKDM4EHTTTDP1KCNH2 | |
| SCHEMBL31033380 | 0.90 | TSHR (0.52) | TSHRKDM4EHTTTDP1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119638666-A | 1, 3-Dithiane substituted cyclobutene derivative and preparation method and application thereof | 兰州大学 | 2025-03-18 | — | — | CN | claimed |
| WO-2001079212-A1 | SILICON DERIVATIVES OF FRAGRANT, FLAVOURING AND MEDICINAL SUBSTANCES | KIREEV VYACHESLAV VASILIEVICH (RU) | 2001-10-25 | — | — | WO | claimed |
| US-12606747-B2 | Surfactant | SPHERE FLUIDICS LIMITED (GB) | 2026-04-21 | — | — | US | disclosed |
| US-12365649-B2 | Process for the preparation of brivaracetam | ALIVUS LIFE SCIENCES LIMITED (IN) | 2025-07-22 | — | — | US | disclosed |
| CN-120118001-A | Aerobic nitriding method for olefin compounds | 北京大学 | 2025-06-10 | — | — | CN | disclosed |
| CN-119638666-A | 1, 3-Dithiane substituted cyclobutene derivative and preparation method and application thereof | 兰州大学 | 2025-03-18 | — | — | CN | disclosed |
| WO-2024175905-A1 | DIMER COMPOUNDS | Kesmalea Therapeutics Limited (GB) | 2024-08-29 | — | — | WO | disclosed |
| EP-4146379-B1 | SURFACTANTS BASED ON PERFLUOROPOLYETHERS OR FLUOROCARBONS | SPHERE FLUIDICS LTD (GB) | 2024-06-26 | — | — | EP | disclosed |
| US-20240010618-A1 | PROCESS FOR THE PREPARATION OF BRIVARACETAM | ALIVUS LIFE SCIENCES LIMITED (IN) | 2024-01-11 | — | — | US | disclosed |
| EP-2775839-B1 | METHODS FOR ASSESSING REPELLANT QUALITY OF ORGANIC MATERIALS AND METHODS AND COMPOSITIONS FOR REPELLING ARTHROPODS | UNIV CALIFORNIA (US) | 2023-12-06 | — | — | EP | disclosed |
| US-20230193137-A1 | Surfactant | SPHERE FLUIDICS LIMITED (GB) | 2023-06-22 | — | — | US | disclosed |
| WO-2014001092-A1 | ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2014-01-03 | — | — | WO | disclosed |
| WO-2008092981-A1 | NOVEL MOLECULE WITH SANDALWOOD FRAGRANCE, METHOD FOR PREPARATION THEREOF AND USE THEREOF AS AN ODORANT | UNIVERSIDAD DE JAÉN (ES) | 2008-08-07 | — | — | WO | disclosed |
| US-7390926-B2 | Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 | ZACH SYSTEM (IT) | 2008-06-24 | — | — | US | disclosed |
| US-7390926-B2 | Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 | ZACH SYSTEM (IT) | 2008-06-24 | — | — | US | disclosed |
| US-20070225516-A1 | Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 | PPG-SIPSY (FR) | 2007-09-27 | — | — | US | disclosed |
| US-20070225516-A1 | Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 | PPG-SIPSY (FR) | 2007-09-27 | — | — | US | disclosed |
| EP-0406742-B1 | PROCESS FOR THE PREPARATION OF CIS-DIHYDRONOPOL | Kali-Chemie Pharma GmbH (DE) | 1993-04-21 | — | — | EP | disclosed |
| US-5175347-A | Hydogenation of a ester compound in presence of hydrogen using solid catalyst | KALI-CHEMIE PHARMA GMBH (DE) | 1992-12-29 | — | — | US | disclosed |
| US-4424374-A | Bicycloheptane derivatives | MAY & BAKER LIMITED (GB) | 1984-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606747-B2 | Surfactant | SGMS1, SGMS2, AQP1 | TSHR 948/4885KDM4E 3302/4885HTT 4276/4885 |
| US-20070225516-A1 | Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 | NOP2, NOP10, NOP56 | TSHR 2265/4885KDM4E 1677/4885HTT 4778/4885 |
| US-12365649-B2 | Process for the preparation of brivaracetam | CYP2C19, CYP2B6, POR | TSHR 865/4885KDM4E 1365/4885HTT 3909/4885 |
| US-20240010618-A1 | PROCESS FOR THE PREPARATION OF BRIVARACETAM | CYP2C19, CYP2B6, POR | TSHR 865/4885KDM4E 1365/4885HTT 3909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.